Riskpilot← Back to searchSign inGet full accessBIO-Y A/S
A/SActiveCVR 25507800Nordlysvænget 10AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20001 employees
Revenue 2024
DKK -44K
+9% vs 2023
EBITDA margin
1209.3%
-1% vs 2023
Equity ratio
-181.3%
Financial strength
Net profit 2024
DKK -1M
-29% vs 2023
| Revenue | DKK -44K | +9% |
| EBITDA | DKK -528K | -1% |
| Net profit | DKK -1M | -29% |
| Total assets | DKK 2,1M | -36% |
| Equity | DKK -3,7M | -37% |
| Employees | 1 | — |
Legal name
BIO-Y A/S
CVR number
25507800
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15. juli 2000
Share capital
DKK 8.761.500
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og et andet medlem af bestyrelsen i forening eller af bestyrelsesformanden og en direktør i forening eller af en direktør alene.
Company purpose
Selskabets formål er forskning, handel og industri samt at foretage investering i aktier og andre værdipapir.
Address
Nordlysvænget 10A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -24 | — | — | -80 | -187 | -376 | -165 | 1.349 | -69 | -39 | -51 | -40 | -44 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -482 | -484 | -483 | -485 | -370 | -485 | -485 |
| EBITDA | -24 | -50 | -140 | -80 | -187 | -376 | -646 | 865 | -552 | -524 | -421 | -525 | -528 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -8.455 | -930 | -416 | -133 | -58 | -1.197 | -300 | -578 |
| EBIT | -24 | -50 | -140 | -80 | -187 | -8.831 | -1.576 | 449 | -685 | -582 | -1.618 | -824 | -1.107 |
| Net financials | 0 | 0 | 0 | 1 | -27 | -4 | -4 | -8 | -18 | -17 | -14 | 0 | 35 |
| Profit before tax | -24 | -50 | -140 | -79 | -214 | -8.835 | -1.580 | 441 | -703 | -599 | -1.632 | -824 | -1.072 |
| Tax | 200 | -79 | -0 | -0 | -169 | 15 | -131 | -0 | -7 | -97 | -243 | -41 | -59 |
| Net profit | -225 | 29 | -140 | -79 | -45 | -8.850 | -1.449 | 441 | -696 | -502 | -1.390 | -783 | -1.013 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.525 | 7.000 | 7.210 | 8.108 | 8.784 | 1.074 | 1.002 | 3.045 | 2.353 | 1.739 | 1.218 | 3.228 | 2.050 |
| Equity | 1.775 | 1.805 | 1.664 | 1.585 | 1.540 | -6.172 | -6.621 | -2.959 | -3.654 | -4.156 | -4.546 | -2.704 | -3.717 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.749 | 5.196 | 5.546 | 6.523 | 7.243 | 7.246 | 7.623 | 6.004 | 6.007 | 5.896 | 5.764 | 5.932 | 5.767 |
| Total debt | 4.749 | 5.196 | 5.546 | 6.523 | 7.243 | 7.246 | 7.623 | 6.004 | 6.007 | 5.896 | 5.764 | 5.932 | 5.767 |
EBITDA margin
-52821900.0%
This company
15.8%
Market median
-334315923% vs market
20122024
Equity ratio
-181.3%
This company
38.2%
Market median
-575% vs market
20122024
Return on equity
-101305300.0%
This company
18.4%
Market median
-550572383% vs market
20122024
Net profit margin
-101305300.0%
This company
8.1%
Market median
-1250682816% vs market
20122024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122024
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2000 | — | — |
CE | Audit | 2000 | — | — |
TB Management | Management | 2000 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2004 | — | — | |
| Board of Directors | 2000 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Holdingselskabet af 26. oktober 2023 ApS | Company | 50.0% | 50.0% | 2023 |
| Individual | 15.0% | 10.0% | 2019 | |
| Individual | 5.0% | 5.0% | 2018 | |
| Individual | 10.0% | 10.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2012 | |
Investeringsselskabet GD ApS | Company | 50.0% | 50.0% | 2022 |
| Individual | 5.0% | 5.0% | 2016 | |
| Individual | 5.0% | 5.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIO-Y A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Schierbeck | Management | 0 companies |
| Carl Edvard Gudbergsen | Audit | 0 companies |
| Tom Barthel Hansen | Management | 0 companies |
| Ole Frands Sigetty | Chairman | 0 companies |
| Britta Madsen | Board of Directors | 0 companies |
| Geoffrey Llewellyn Carter | Chairman | 0 companies |
| Vera Lykkesborg Petersen | Board of Directors | 0 companies |
| Kai Frode Christensen | Board of Directors | 0 companies |
| Daniel Bøøk Bonnichsen | Board of Directors | 0 companies |